Literature DB >> 10579551

Diagnostic efficiency of the Rorschach schizophrenia and depression indices in identifying first-episode schizophrenia and severe depression

.   

Abstract

We studied the diagnostic efficiency of the Rorschach schizophrenia (SCZI) and depression (DEPI) indices for detecting first-episode schizophrenia and severe depression with and without psychotic features using DSM-IV as a gold standard measure. Twenty-seven patients with first-episode schizophrenia, 13 with bipolar I disorder, 28 with psychotic depression, 29 with non-psychotic depression, and 60 healthy controls were recruited for the study. The SCZI was highly specific with a very low false positive rate. The lowest positive value of 4, however, may yield false positives, especially among manic patients. The DEPI identified severe non-psychotic depression but not psychotic depression, suggesting that these patient groups invoke different perceptual-cognitive processes in formulating and articulating their Rorschach responses. Anyway, both the SCZI and the DEPI based on the psychological organization and functioning that are known to play a clearly formulated role in schizophrenia and depression, respectively, provide a valuable addition for diagnostics characterized by overt symptoms.

Entities:  

Year:  1999        PMID: 10579551     DOI: 10.1016/s0165-1781(99)00061-x

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  3 in total

1.  Detecting incipient schizophrenia: a validation of the Azima battery in first episode psychosis.

Authors:  Hiba Zafran; Barbara Mazer; Beverlea Tallant; Gevorg Chilingaryan; Isabelle Gelinas
Journal:  Psychiatr Q       Date:  2017-09

2.  Rorschach inkblot test and psychopathology among patients suffering from schizophrenia: A correlational study.

Authors:  Anwesha Mondal; Manish Kumar
Journal:  Ind Psychiatry J       Date:  2021-06-04

3.  Convergent and divergent functional connectivity patterns in schizophrenia and depression.

Authors:  Yang Yu; Hui Shen; Ling-Li Zeng; Qiongmin Ma; Dewen Hu
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.